SkyView Investment Advisors’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

SkyView Investment Advisors’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$35K	–	558
2023 Q3	$35K	Hold	100,000	–	–	0.01%	295
2023 Q2	$17K	Hold	100,000	–	–	﹤0.01%	438
2023 Q1	$15K	Hold	100,000	–	–	﹤0.01%	438
2022 Q4	$6K	Hold	100,000	–	–	﹤0.01%	436
2022 Q3	$4K	Hold	100,000	–	–	﹤0.01%	503
2022 Q2	$11K	Hold	100,000	–	–	﹤0.01%	509
2022 Q1	$18K	Hold	100,000	–	–	﹤0.01%	510
2021 Q4	$32K	Buy	+100,000	New	+$31.6K	0.01%	476

Other funds holding DMAQR

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

SOA

Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

SkyView Investment Advisors's DMAQR Position: Q4 2023 in Review

SkyView Investment Advisors sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q4 2023, closing a stake of 100,000 shares — an estimated $35K sold.

SkyView Investment Advisors first reported a position in DMAQR in Q4 2021 and held it in 8 quarters. The position peaked at $35K in Q3 2023. 24 funds tracked by Wall St. Rank hold DMAQR as of Q4 2023.

SkyView Investment Advisors reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q4 2023 after selling out during the quarter.
SkyView Investment Advisors sold 100,000 Deep Medicine Acquisition Corp. Rights shares in Q4 2023, an estimated $35K.
SkyView Investment Advisors first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 8 quarters.
SkyView Investment Advisors's Deep Medicine Acquisition Corp. Rights position peaked at $35K in Q3 2023.
24 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q4 2023.

Based on SkyView Investment Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.